Hyung Heon Kim serves as Executive at NeuroBo Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Hyung Heon Kim has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 32,000 shares valued at $0.
Hyung Heon Kim currently holds 37,545 shares of NeuroBo Pharmaceuticals, Inc. (NRBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hyung Heon Kim has been a net neutral trader of NRBO stock. They have purchased $0 and sold $0 worth of shares.
Hyung Heon Kim's most recent insider trade was on Jan 23, 2026, when they sold 32,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.60 |
| Discretionary |
| Aug 11, 2023 | NRBO | $0 | Award | 625,064 | $N/A | Discretionary |